These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 26389154)
41. Application of tumor measurement-based metrics in the real world. An MW; Mandrekar SJ; Sargent DJ J Clin Oncol; 2013 Dec; 31(34):4374. PubMed ID: 24166528 [No Abstract] [Full Text] [Related]
42. Assessment of tumor growth inhibition metrics to predict overall survival. Claret L; Bruno R Clin Pharmacol Ther; 2014 Aug; 96(2):135-7. PubMed ID: 25056390 [No Abstract] [Full Text] [Related]
44. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS]. Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159 [TBL] [Abstract][Full Text] [Related]
45. New lessons from "old" chemotherapy in colorectal cancer. Grothey A; Sargent DJ J Clin Oncol; 2008 Oct; 26(28):4532-4. PubMed ID: 18824704 [No Abstract] [Full Text] [Related]
46. Therapeutic strategies for colorectal cancer in Europe and the United States: focus on chemotherapy for advanced colorectal cancer. Bennouna J; Douillard JY Int J Clin Oncol; 2002 Aug; 7(4):236-44. PubMed ID: 12202977 [No Abstract] [Full Text] [Related]
48. Reply to U.R. Mansmann et al and M.-W. An et al. Claret L; Bruno R J Clin Oncol; 2013 Dec; 31(34):4374-5. PubMed ID: 24166517 [No Abstract] [Full Text] [Related]
50. Pathological response to neoadjuvant chemotherapy: a new prognosis tool for the curative management of peritoneal colorectal carcinomatosis. Passot G; You B; Boschetti G; Fontaine J; Isaac S; Decullier E; Maurice C; Vaudoyer D; Gilly FN; Cotte E; Glehen O Ann Surg Oncol; 2014 Aug; 21(8):2608-14. PubMed ID: 24668148 [TBL] [Abstract][Full Text] [Related]
51. Chemotherapy-free intervals in patients with metastatic colorectal cancer: a tale of two cities? Beretta GD; Scartozzi M; Tondulli L; Cascinu S J Clin Oncol; 2010 Jun; 28(16):e268-9; author reply e270. PubMed ID: 20385975 [No Abstract] [Full Text] [Related]
53. [Pre-operative chemotherapy for patients with hepatic metastases from colorectal cancer]. Gu J; Yao YF Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):158-9. PubMed ID: 17645861 [No Abstract] [Full Text] [Related]
54. Control arm for surgery alone is needed but difficult to obtain in randomized trials for adjuvant chemotherapy after liver resection for colorectal metastases. Kokudo N; Hasegawa K; Makuuchi M J Clin Oncol; 2007 Apr; 25(10):1299-300; author reply 1300. PubMed ID: 17401028 [No Abstract] [Full Text] [Related]
55. Chemotherapy with irinothecan, 5-fluorouracil and folinic acid in the first-line management of advanced colorectal carcinoma: retrospective study. Man S; Lavrenkov K; Gluzman A; Geffen DB; Cohen Y J Chemother; 2003 Jun; 15(3):304-5. PubMed ID: 12868563 [No Abstract] [Full Text] [Related]
56. Chemotherapy Maintenance. Kasi PM; Grothey A Cancer J; 2016; 22(3):199-204. PubMed ID: 27341599 [TBL] [Abstract][Full Text] [Related]
57. [Hepatic intra-arterial 5-fluorouracil and CDDP administration in patients with colorectal cancer metastasis to the liver]. Arai T; Okabe S; Maruyama S; Murase N; Tada M; Yabata E; Endou M Gan To Kagaku Ryoho; 1996 Sep; 23(11):1447-50. PubMed ID: 8854776 [TBL] [Abstract][Full Text] [Related]